Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Integrated Animals is a virtual database currently indexing available animal strains and mutants from: AGSC (Ambystoma), BCBC (mice), BDSC (flies), European Xenopus Resource Center (frog), The National Xenopus Resource (frog), Xenopus Express (frog), CWRU Cystic Fibrosis Mouse Models (mice), DGGR (flies), FlyBase (flies), IMSR (mice), MGI (mice), MMRRC (mice), NSRRC (pig), RGD (rats), Sperm Stem Cell Libraries for Biological Research (rats), Tetrahymena Stock Center (Tetrahymena), WormBase (worms), XGSC (Xiphophorus), ZFIN (zebrafish), and ZIRC (zebrafish). Note, the IMSR data is linked, but users may need to re-execute the search if the top mouse is not returned properly.
Note: BCBC is no longer in service, so the links may not be functional.
| Organism Name | Proper Citation | Species | Synonyms |
Notes |
Phenotype | Affected Gene | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NOD.B6-Prkdcscid B2m Resource Report Resource Website Issue |
RRID:IMSR_APB:4135 | Mus musculus | gene symbol note: |protein kinase; DNA activated; catalytic polypeptide|beta-2 microglobulin; mutant strain|congenic strain: |Prkdc|B2m | |protein kinase; DNA activated; catalytic polypeptide|beta-2 microglobulin | transgene insertion 1; Robyn M Slattery|severe combined immunodeficiency|targeted mutation 1; Rudolf Jaenisch | APB:4135 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:22 | 0 | |||||
|
BALB/c-Tlr2tm1Aki/AnuApb Resource Report Resource Website Issue |
RRID:IMSR_APB:4453 | Mus musculus |
C.129P2-Tlr2 |
gene symbol note: toll-like receptor 2; mutant strain: Tlr2 | toll-like receptor 2 | targeted mutation 1; Shizuo Akira | APB:4453 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:22 | 0 | ||||
|
C.B6-TLR2tm1Aki TLR4 Resource Report Resource Website Issue |
RRID:IMSR_APB:4476 | Mus musculus |
C.129P2(B6)-TLR2 |
gene symbol note: toll-like receptor 4|toll-like receptor 2; mutant strain: Tlr4|Tlr2 | toll-like receptor 4|toll-like receptor 2 | targeted mutation 1; Shizuo Akira | APB:4476 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:22 | 0 | ||||
|
NOD.B6-B2mtm1Jae Tg(B2mb)1Rms Tg(TcraTcrbNY8.3)1Pesa/MarpApb Resource Report Resource Website Issue |
RRID:IMSR_APB:4704 | Mus musculus | gene symbol note: |beta-2 microglobulin; mutant strain: |B2m | |beta-2 microglobulin | transgene insertion 1; Robyn M Slattery|targeted mutation 1; Rudolf Jaenisch|transgene insertion 1; Pere Santamaria | APB:4704 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:23 | 0 | |||||
|
C.B6(129)-Ifngtm1Ts/AnuApb Resource Report Resource Website Issue |
RRID:IMSR_APB:4778 | Mus musculus |
STOCK Ifng |
gene symbol note: interferon gamma; mutant strain: Ifng | interferon gamma | targeted mutation 1; Timothy Stewart | APB:4778 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:25 | 0 | ||||
|
MRL/MpJ-Faslpr/MarpApb Resource Report Resource Website Issue |
RRID:IMSR_APB:4602 | Mus musculus | gene symbol note: Fas cell surface death receptor; mutant strain: Fas | Fas cell surface death receptor | lymphoproliferation | APB:4602 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:23 | 0 | |||||
|
C57BL/6-Igh-6tm1Cgn Ggta Resource Report Resource Website 1+ mentions Issue Issue |
RRID:IMSR_APB:4877 | Mus musculus |
B6.Cg-Ggta1 |
gene symbol note: immunoglobulin heavy constant mu; mutant strain: Ighm | immunoglobulin heavy constant mu | targeted mutation 1; University of Cologne | APB:4877 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:25 | 2 | ||||
|
MRL/MpJ.Cg-Faslpr Mif Resource Report Resource Website Issue |
RRID:IMSR_APB:5181 | Mus musculus | gene symbol note: macrophage migration inhibitory factor (glycosylation-inhibiting factor)|Fas cell surface death receptor; mutant strain: Mif|Fas | macrophage migration inhibitory factor (glycosylation-inhibiting factor)|Fas cell surface death receptor | targeted mutation 1; John R David|lymphoproliferation | APB:5181 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:27 | 0 | |||||
|
NOD-B2mtm1Jae Prkdc Resource Report Resource Website Issue |
RRID:IMSR_APB:5335 | Mus musculus |
NOD.Cg-B2m |
gene symbol note: beta-2 microglobulin|protein kinase; DNA activated; catalytic polypeptide; mutant strain: B2m|Prkdc | beta-2 microglobulin|protein kinase; DNA activated; catalytic polypeptide | targeted mutation 1; Rudolf Jaenisch|severe combined immunodeficiency | APB:5335 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:28 | 0 | ||||
|
NOD-B2mtm1Jae Tg(B2m)1Rms Tg(TcraTcrbNY8.3)1Pesa/MarpApb Resource Report Resource Website Issue |
RRID:IMSR_APB:5334 | Mus musculus | gene symbol note: |beta-2 microglobulin; mutant strain: |B2m | |beta-2 microglobulin | Tg(TcraTcrbNY8.3)1Pesa|targeted mutation 1; Rudolf Jaenisch|transgene insertion 1; Robyn M Slattery | APB:5334 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:26 | 0 | |||||
|
B6.129-Apoetm1Unc Cybb Resource Report Resource Website Issue |
RRID:IMSR_APB:6804 | Mus musculus | gene symbol note: apolipoprotein E|cytochrome b-245; beta polypeptide; mutant strain: Apoe|Cybb | apolipoprotein E|cytochrome b-245; beta polypeptide | targeted mutation 1; University of North Carolina|targeted mutation 1; Mary C Dinauer | APB:6804 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:29 | 0 | |||||
|
B6;129S1(Cg)-Lmnatm1Stw/Dfat Resource Report Resource Website Issue |
RRID:IMSR_APB:5581 | Mus musculus |
STOCK Lmna |
gene symbol note: lamin A; congenic strain|closed colony: Lmna | lamin A | targeted mutation 1; Colin L Stewart | APB:5581 | Australian Phenome Bank | APB | sperm | 2026-07-24 10:31:28 | 0 | ||||
|
B6;129P2-Rhdtm1Goo Rhag Resource Report Resource Website Issue |
RRID:IMSR_EM:11708 | Mus musculus | Rhdtm1GOOxRhagtm1GOO. GOO1 x GOO2 | gene symbol note: Rh associated glycoprotein|Rh blood group; D antigen; mutant strain: Rhag|Rhd | Rh associated glycoprotein|Rh blood group; D antigen | targeted mutation 1; Dominique Goossens | EM:11708 | European Mouse Mutant Archive | EMMA | archived | 2026-07-24 10:30:38 | 0 | ||||
|
B6.Cg-Apoetm1Unc Lipctm1Unc Tg(LIPC*S145G)1Ssf/Mmmh Resource Report Resource Website Issue |
RRID:MMRRC_011858-MU | Mus musculus | Research areas: Cardiovascular, Metabolism, Models for Human Disease; Mutation Type: Transgenic ; Collection: | abnormal cochlea morphology [MP:0000031]| organ of Corti degeneration [MP:0000043]| abnormal stria vascularis morphology [MP:0000048]| increased bone mineral density [MP:0000062]| decreased bone mineral density [MP:0000063]| abnormal trabecular bone morphology [MP:0000130]| abnormal vertebrae morphology [MP:0000137]| abnormal circulating cholesterol level [MP:0000180]| increased circulating LDL cholesterol level [MP:0000182]| decreased circulating HDL cholesterol level [MP:0000186]| decreased hematocrit [MP:0000208]| increased monocyte cell number [MP:0000220]| decreased monocyte cell number [MP:0000223]| hypertension [MP:0000231]| abnormal blood flow velocity [MP:0000233]| macrocytosis [MP:0000248]| abnormal blood vessel physiology [MP:0000249]| echinocytosis [MP:0000256]| abnormal heart morphology [MP:0000266]| abnormal aorta morphology [MP:0000272]| enlarged heart [MP:0000274]| altered response to myocardial infarction [MP:0000343]| decreased hair follicle number [MP:0000379]| alopecia [MP:0000414]| sparse hair [MP:0000416]| abnormal femur morphology [MP:0000559]| abnormal liver morphology [MP:0000598]| amyloidosis [MP:0000604]| abnormal liver physiology [MP:0000609]| abnormal adrenal gland morphology [MP:0000639]| abnormal immune system morphology [MP:0000685]| enlarged spleen [MP:0000691]| enlarged lymph nodes [MP:0000702]| enlarged thymus [MP:0000709]| abnormal skin condition [MP:0001191]| thick skin [MP:0001200]| skin lesions [MP:0001212]| hyperkeratosis [MP:0001242]| abnormal dermal layer morphology [MP:0001243]| thick dermal layer [MP:0001245]| mixed cellular infiltration to dermis [MP:0001246]| decreased body length [MP:0001258]| increased body weight [MP:0001260]| obese [MP:0001261]| decreased body weight [MP:0001262]| abnormal retina morphology [MP:0001325]| dry eyes [MP:0001337]| Meibomian gland atrophy [MP:0001345]| increased anxiety-related response [MP:0001363]| abnormal stationary movement [MP:0001388]| abnormal locomotor behavior [MP:0001392]| abnormal response to new environment [MP:0001413]| decreased exploration in new environment [MP:0001417]| abnormal spatial learning [MP:0001463]| increased startle reflex [MP:0001488]| decreased startle reflex [MP:0001489]| abnormal kindling response [MP:0001499]| abnormal coat appearance [MP:0001510]| abnormal skeleton physiology [MP:0001533]| abnormal hematopoietic system physiology [MP:0001545]| abnormal lipid level [MP:0001547]| hyperlipidemia [MP:0001548]| increased circulating triglyceride level [MP:0001552]| increased circulating free fatty acid level [MP:0001554]| increased circulating HDL cholesterol level [MP:0001556]| hyperglycemia [MP:0001559]| anemia [MP:0001577]| cardiac hypertrophy [MP:0001625]| hypersecretion of corticosterone [MP:0001744]| increased circulating corticosterone level [MP:0001745]| abnormal immune system physiology [MP:0001790]| impaired macrophage phagocytosis [MP:0001798]| abnormal inflammatory response [MP:0001845]| heart inflammation [MP:0001853]| kidney inflammation [MP:0001859]| lung inflammation [MP:0001861]| vascular inflammation [MP:0001863]| abnormal lung volume [MP:0001942]| deafness [MP:0001967]| abnormal skin morphology [MP:0002060]| abnormal fear/anxiety-related behavior [MP:0002065]| increased circulating insulin level [MP:0002079]| premature death [MP:0002083]| abnormal lipid homeostasis [MP:0002118]| abnormal cardiovascular system morphology [MP:0002127]| abnormal kidney morphology [MP:0002135]| abnormal brain morphology [MP:0002152]| abnormal gland physiology [MP:0002164]| gliosis [MP:0002183]| abnormal artery morphology [MP:0002191]| neurodegeneration [MP:0002229]| abnormal pulmonary alveolus morphology [MP:0002270]| abnormal lymph node morphology [MP:0002339]| abnormal dendritic cell physiology [MP:0002376]| abnormal cell-mediated immunity [MP:0002421]| abnormal macrophage morphology [MP:0002446]| abnormal erythrocyte morphology [MP:0002447]| abnormal macrophage physiology [MP:0002451]| increased immunoglobulin level [MP:0002461]| abnormal neutrophil physiology [MP:0002463]| increased IgG level [MP:0002493]| increased IgM level [MP:0002494]| abnormal blood coagulation [MP:0002551]| hepatic steatosis [MP:0002628]| reticulocytosis [MP:0002640]| poikilocytosis [MP:0002643]| decreased circulating triglyceride level [MP:0002644]| abnormal sciatic nerve morphology [MP:0002651]| abnormal immune serum protein physiology [MP:0002723]| decreased circulating insulin level [MP:0002727]| abnormal thermal nociception [MP:0002733]| glomerulonephritis [MP:0002743]| dilated heart left ventricle [MP:0002753]| decreased vertical activity [MP:0002757]| abnormal retinal vasculature morphology [MP:0002792]| increased thigmotaxis [MP:0002797]| increased heart weight [MP:0002833]| increased systemic arterial blood pressure [MP:0002842]| decreased systemic arterial blood pressure [MP:0002843]| cochlear ganglion degeneration [MP:0002857]| increased growth rate [MP:0002865]| albuminuria [MP:0002871]| decreased hemoglobin content [MP:0002874]| increased insulin sensitivity [MP:0002891]| thick ventricular wall [MP:0002953]| increased urine protein level [MP:0002962]| increased liver weight [MP:0002981]| abnormal cytokine secretion [MP:0003009]| increased vasoconstriction [MP:0003025]| decreased myocardial infarction size [MP:0003038]| abnormal impulse conducting system conduction [MP:0003137]| cardiac fibrosis [MP:0003141]| abnormal tectorial membrane morphology [MP:0003149]| impaired muscle relaxation [MP:0003157]| increased cholesterol efflux [MP:0003192]| amyloid beta deposits [MP:0003329]| hypopituitarism [MP:0003348]| increased cardiac output [MP:0003394]| abnormal nervous system physiology [MP:0003633]| abnormal response/metabolism to endogenous compounds [MP:0003638]| abnormal axon extension [MP:0003651]| oxidative stress [MP:0003674]| xanthoma [MP:0003692]| increased autoantibody level [MP:0003725]| decreased autoantibody level [MP:0003726]| abnormal retinal inner nuclear layer morphology [MP:0003733]| abnormal bone structure [MP:0003795]| impaired macrophage chemotaxis [MP:0003799]| vascular smooth muscle hypoplasia [MP:0003814]| enhanced coordination [MP:0003858]| abnormal myelin sheath morphology [MP:0003871]| decreased macrophage cell number [MP:0003884]| abnormal ST segment [MP:0003897]| decreased kidney weight [MP:0003918]| abnormal lymphocyte physiology [MP:0003945]| abnormal cholesterol level [MP:0003947]| abnormal circulating lipid level [MP:0003949]| increased circulating VLDL triglyceride level [MP:0003975]| increased circulating phospholipid level [MP:0003980]| increased cholesterol level [MP:0003982]| decreased cholesterol level [MP:0003983]| arteriosclerosis [MP:0003991]| aortic dissection [MP:0004044]| abnormal coronary artery morphology [MP:0004111]| abnormal aortic arch morphology [MP:0004113]| increased compact bone thickness [MP:0004148]| increased renal tubule apoptosis [MP:0004153]| abnormal basilar membrane morphology [MP:0004308]| cochlear inner hair cell degeneration [MP:0004398]| cochlear outer hair cell degeneration [MP:0004404]| abnormal spiral modiolar artery morphology [MP:0004629]| spiral modiolar artery stenosis [MP:0004630]| increased anti-double stranded DNA antibody level [MP:0004762]| abnormal synaptic vesicle morphology [MP:0004769]| increased macrophage derived foam cell number [MP:0004778]| increased anti-nuclear antigen antibody level [MP:0004794]| increased susceptibility to systemic lupus erythematosus [MP:0004801]| increased mean systemic arterial blood pressure [MP:0004875]| decreased systemic vascular resistance [MP:0004879]| abnormal vascular wound healing [MP:0004883]| decreased adiponectin level [MP:0004893]| increased uterus weight [MP:0004904]| skin inflammation [MP:0004947]| increased spleen weight [MP:0004952]| abnormal osteoblast physiology [MP:0005006]| increased B cell number [MP:0005014]| increased T cell number [MP:0005015]| decreased T cell number [MP:0005018]| increased susceptibility to parasitic infection [MP:0005027]| abnormal thrombosis [MP:0005048]| decreased acute inflammation [MP:0005087]| decreased cardiac muscle contractility [MP:0005140]| increased circulating VLDL cholesterol level [MP:0005145]| decreased circulating VLDL cholesterol level [MP:0005146]| abnormal blood-brain barrier function [MP:0005167]| increased circulating cholesterol level [MP:0005178]| decreased circulating cholesterol level [MP:0005179]| glomerulosclerosis [MP:0005264]| abnormal cholesterol homeostasis [MP:0005278]| improved glucose tolerance [MP:0005292]| impaired glucose tolerance [MP:0005293]| abnormal circulating amino acid level [MP:0005311]| increased triglyceride level [MP:0005317]| abnormal enzyme/coenzyme level [MP:0005319]| abnormal renal glomerulus morphology [MP:0005325]| insulin resistance [MP:0005331]| abnormal gonadal fat pad morphology [MP:0005335]| atherosclerotic lesions [MP:0005338]| increased susceptibility to atherosclerosis [MP:0005339]| altered susceptibility to atherosclerosis [MP:0005340]| decreased susceptibility to atherosclerosis [MP:0005341]| abnormal bile salt homeostasis [MP:0005365]| vascular stenosis [MP:0005412]| abnormal circulating protein level [MP:0005416]| increased macrophage cell number [MP:0005425]| increased susceptibility to weight gain [MP:0005455]| vascular smooth muscle hyperplasia [MP:0005489]| abnormal eye electrophysiology [MP:0005551]| increased circulating creatinine level [MP:0005553]| increased circulating glucose level [MP:0005559]| decreased circulating glucose level [MP:0005560]| abnormal enzyme/coenzyme activity [MP:0005584]| increased vasodilation [MP:0005590]| decreased vasodilation [MP:0005591]| abnormal vascular smooth muscle morphology [MP:0005592]| abnormal vascular smooth muscle physiology [MP:0005595]| decreased susceptibility to type IV hypersensitivity reaction [MP:0005616]| decreased susceptibility to diet-induced obesity [MP:0005659]| decreased circulating leptin level [MP:0005668]| increased circulating leptin level [MP:0005669]| increased apoptosis [MP:0006042]| abnormal vascular endothelial cell morphology [MP:0006055]| decreased cerebral infarction size [MP:0006058]| increased cerebral infarction size [MP:0006060]| abnormal circulating homocysteine level [MP:0006076]| increased fat cell size [MP:0006094]| calcified artery [MP:0006133]| artery occlusion [MP:0006134]| increased systemic arterial systolic blood pressure [MP:0006144]| decreased systemic arterial systolic blood pressure [MP:0006264]| aortic aneurysm [MP:0006278]| abnormal T cell number [MP:0006387]| delayed cellular replicative senescence [MP:0008009]| impaired lipolysis [MP:0008033]| abnormal CD4-positive [MP:0008073]| alpha beta T cell number [MP:0008074]| increased CD4-positive [MP:0008075]| alpha beta T cell number [MP:0008079]| decreased CD4-positive [MP:0008090]| alpha beta T cell number [MP:0008143]| decreased CD8-positive [MP:0008174]| alpha-beta T cell number [MP:0008181]| increased T-helper 2 cell number [MP:0008182]| abnormal dendrite morphology [MP:0008217]| decreased follicular B cell number [MP:0008243]| increased marginal zone B cell number [MP:0008248]| decreased marginal zone B cell number [MP:0008288]| abnormal B cell activation [MP:0008289]| abnormal macrophage derived foam cell morphology [MP:0008389]| abnormal mononuclear phagocyte morphology [MP:0008406]| abnormal adrenal cortex morphology [MP:0008428]| abnormal adrenal medulla morphology [MP:0008511]| hypochromic macrocytic anemia [MP:0008515]| increased cellular sensitivity to hydrogen peroxide [MP:0008544]| abnormal spatial working memory [MP:0008553]| thin retinal inner nuclear layer [MP:0008561]| thin retinal outer nuclear layer [MP:0008566]| impaired olfaction [MP:0008567]| increased circulating tumor necrosis factor level [MP:0008577]| decreased tumor necrosis factor secretion [MP:0008596]| increased interferon-gamma secretion [MP:0008597]| decreased interferon-gamma secretion [MP:0008617]| increased circulating interferon-gamma level [MP:0008660]| increased circulating interleukin-6 level [MP:0008817]| decreased circulating interleukin-6 level [MP:0008916]| increased circulating interleukin-12 level [MP:0009278]| increased interleukin-10 secretion [MP:0009289]| hematoma [MP:0009346]| abnormal astrocyte physiology [MP:0009538]| abnormal bone marrow cell physiology [MP:0009763]| decreased epididymal fat pad weight [MP:0009764]| decreased trabecular bone thickness [MP:0009814]| abnormal synapse morphology [MP:0009862]| increased sensitivity to induced morbidity/mortality [MP:0009864]| decreased sensitivity to induced morbidity/mortality [MP:0009866]| increased prostaglandin level [MP:0009868]| abnormal aorta elastic tissue morphology [MP:0009873]| abnormal aorta endothelium morphology [MP:0009932]| abnormal aorta wall morphology [MP:0010210]| abnormal descending thoracic aorta morphology [MP:0010451]| abnormal aorta tunica media morphology [MP:0010483]| skin fibrosis [MP:0010574]| abnormal circulating cytokine level [MP:0010658]| kidney microaneurysm [MP:0010659]| aortic sinus aneurysm [MP:0010663]| aorta dilation [MP:0010724]| thoracic aorta aneurysm [MP:0010760]| abdominal aorta aneurysm [MP:0010868]| abnormal brachiocephalic trunk morphology [MP:0010869]| thick interventricular septum [MP:0010879]| abnormal macrophage chemotaxis [MP:0010895]| increased bone trabecula number [MP:0010922]| decreased bone trabecula number [MP:0010933]| decreased trabecular bone volume [MP:0010935]| increased lung compliance [MP:0010950]| alveolitis [MP:0011086]| decreased trabecular bone connectivity density [MP:0011231]| increased airway resistance [MP:0011294]| abnormal lung hysteresivity [MP:0011309]| postnatal lethality [MP:0011339]| incomplete penetrance [MP:0011353]| abnormal vitamin E level [MP:0011368]| renal glomerulus hypertrophy [MP:0011430]| abnormal kidney arterial blood vessel morphology [MP:0011477]| abnormal glomerular mesangium morphology [MP:0011508]| expanded mesangial matrix [MP:0011509]| increased kidney apoptosis [MP:0011561]| mesangiolysis [MP:0011567]| abnormal urine nucleoside level [MP:0011572]| glomerular capillary thrombosis [MP:0011578]| dilated glomerular capillary [MP:0011581]| renal glomerulus lipidosis [MP:0011599]| increased renal glomerulus lobularity [MP:0011939]| abnormal aorta bulb morphology [MP:0011941]| increased lipoprotein lipase activity [MP:0011951]| increased triglyceride lipase activity [MP:0011967]| increased phosphatidylcholine-sterol O-acyltransferase activity [MP:0012307]| increased food intake [MP:0012335]| increased fluid intake [MP:0013022]| increased cardiac stroke volume [MP:0014169]| increased or absent threshold for auditory brainstem response [MP:0020253]| impaired spatial learning [MP:0020408]| increased circulating homocysteine level [MP:0020519]| abnormal circulating cholesterol level [MP:0000180]| increased circulating LDL cholesterol level [MP:0000182]| small ovary [MP:0001127]| abnormal lipid level [MP:0001547]| increased circulating triglyceride level [MP:0001552]| increased circulating HDL cholesterol level [MP:0001556]| abnormal reproductive system physiology [MP:0001919]| decreased litter size [MP:0001935]| decreased circulating corticosterone level [MP:0002665]| decreased ovulation rate [MP:0003355]| increased circulating cholesterol level [MP:0005178]| abnormal circulating phospholipid level [MP:0006084] | |LIPC||Apoe||Lipc | 011858-MU | Transgenic | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | PMID:15304509 | MMRRC_11858-MU, MMRRC_011858, MMRRC_11858 | 2026-07-25 09:37:21 | 0 | |||
|
B6J.Cg-Apoetm1Unc Tg(MSR1-Plau)1Ddi/Mmmh Resource Report Resource Website Issue |
RRID:MMRRC_067987-MU | Mus musculus | Research areas: Cardiovascular, Models for Human Disease; Mutation Type: Transgenic ; Collection: | abnormal cochlea morphology [MP:0000031]| organ of Corti degeneration [MP:0000043]| abnormal stria vascularis morphology [MP:0000048]| increased bone mineral density [MP:0000062]| decreased bone mineral density [MP:0000063]| abnormal trabecular bone morphology [MP:0000130]| abnormal vertebrae morphology [MP:0000137]| abnormal circulating cholesterol level [MP:0000180]| increased circulating LDL cholesterol level [MP:0000182]| decreased circulating HDL cholesterol level [MP:0000186]| decreased hematocrit [MP:0000208]| increased monocyte cell number [MP:0000220]| decreased monocyte cell number [MP:0000223]| hypertension [MP:0000231]| abnormal blood flow velocity [MP:0000233]| macrocytosis [MP:0000248]| abnormal blood vessel physiology [MP:0000249]| echinocytosis [MP:0000256]| abnormal heart morphology [MP:0000266]| abnormal aorta morphology [MP:0000272]| enlarged heart [MP:0000274]| altered response to myocardial infarction [MP:0000343]| decreased hair follicle number [MP:0000379]| alopecia [MP:0000414]| sparse hair [MP:0000416]| abnormal femur morphology [MP:0000559]| abnormal liver morphology [MP:0000598]| amyloidosis [MP:0000604]| abnormal liver physiology [MP:0000609]| abnormal adrenal gland morphology [MP:0000639]| abnormal immune system morphology [MP:0000685]| enlarged spleen [MP:0000691]| enlarged lymph nodes [MP:0000702]| enlarged thymus [MP:0000709]| abnormal skin condition [MP:0001191]| thick skin [MP:0001200]| skin lesions [MP:0001212]| hyperkeratosis [MP:0001242]| abnormal dermal layer morphology [MP:0001243]| thick dermal layer [MP:0001245]| mixed cellular infiltration to dermis [MP:0001246]| decreased body length [MP:0001258]| increased body weight [MP:0001260]| obese [MP:0001261]| decreased body weight [MP:0001262]| abnormal retina morphology [MP:0001325]| dry eyes [MP:0001337]| Meibomian gland atrophy [MP:0001345]| increased anxiety-related response [MP:0001363]| abnormal stationary movement [MP:0001388]| abnormal locomotor behavior [MP:0001392]| abnormal response to new environment [MP:0001413]| decreased exploration in new environment [MP:0001417]| abnormal spatial learning [MP:0001463]| increased startle reflex [MP:0001488]| decreased startle reflex [MP:0001489]| abnormal kindling response [MP:0001499]| abnormal coat appearance [MP:0001510]| abnormal skeleton physiology [MP:0001533]| abnormal hematopoietic system physiology [MP:0001545]| abnormal lipid level [MP:0001547]| hyperlipidemia [MP:0001548]| increased circulating triglyceride level [MP:0001552]| increased circulating free fatty acid level [MP:0001554]| increased circulating HDL cholesterol level [MP:0001556]| hyperglycemia [MP:0001559]| anemia [MP:0001577]| cardiac hypertrophy [MP:0001625]| hypersecretion of corticosterone [MP:0001744]| increased circulating corticosterone level [MP:0001745]| abnormal immune system physiology [MP:0001790]| impaired macrophage phagocytosis [MP:0001798]| abnormal inflammatory response [MP:0001845]| heart inflammation [MP:0001853]| kidney inflammation [MP:0001859]| lung inflammation [MP:0001861]| vascular inflammation [MP:0001863]| abnormal lung volume [MP:0001942]| deafness [MP:0001967]| abnormal skin morphology [MP:0002060]| abnormal fear/anxiety-related behavior [MP:0002065]| increased circulating insulin level [MP:0002079]| premature death [MP:0002083]| abnormal lipid homeostasis [MP:0002118]| abnormal cardiovascular system morphology [MP:0002127]| abnormal kidney morphology [MP:0002135]| abnormal brain morphology [MP:0002152]| abnormal gland physiology [MP:0002164]| gliosis [MP:0002183]| abnormal artery morphology [MP:0002191]| neurodegeneration [MP:0002229]| abnormal pulmonary alveolus morphology [MP:0002270]| abnormal lymph node morphology [MP:0002339]| abnormal dendritic cell physiology [MP:0002376]| abnormal cell-mediated immunity [MP:0002421]| abnormal macrophage morphology [MP:0002446]| abnormal erythrocyte morphology [MP:0002447]| abnormal macrophage physiology [MP:0002451]| increased immunoglobulin level [MP:0002461]| abnormal neutrophil physiology [MP:0002463]| increased IgG level [MP:0002493]| increased IgM level [MP:0002494]| abnormal blood coagulation [MP:0002551]| hepatic steatosis [MP:0002628]| reticulocytosis [MP:0002640]| poikilocytosis [MP:0002643]| decreased circulating triglyceride level [MP:0002644]| abnormal sciatic nerve morphology [MP:0002651]| abnormal immune serum protein physiology [MP:0002723]| decreased circulating insulin level [MP:0002727]| abnormal thermal nociception [MP:0002733]| glomerulonephritis [MP:0002743]| dilated heart left ventricle [MP:0002753]| decreased vertical activity [MP:0002757]| abnormal retinal vasculature morphology [MP:0002792]| increased thigmotaxis [MP:0002797]| increased heart weight [MP:0002833]| increased systemic arterial blood pressure [MP:0002842]| decreased systemic arterial blood pressure [MP:0002843]| cochlear ganglion degeneration [MP:0002857]| increased growth rate [MP:0002865]| albuminuria [MP:0002871]| decreased hemoglobin content [MP:0002874]| increased insulin sensitivity [MP:0002891]| thick ventricular wall [MP:0002953]| increased urine protein level [MP:0002962]| increased liver weight [MP:0002981]| abnormal cytokine secretion [MP:0003009]| increased vasoconstriction [MP:0003025]| decreased myocardial infarction size [MP:0003038]| abnormal impulse conducting system conduction [MP:0003137]| cardiac fibrosis [MP:0003141]| abnormal tectorial membrane morphology [MP:0003149]| impaired muscle relaxation [MP:0003157]| increased cholesterol efflux [MP:0003192]| amyloid beta deposits [MP:0003329]| hypopituitarism [MP:0003348]| increased cardiac output [MP:0003394]| abnormal nervous system physiology [MP:0003633]| abnormal response/metabolism to endogenous compounds [MP:0003638]| abnormal axon extension [MP:0003651]| oxidative stress [MP:0003674]| xanthoma [MP:0003692]| increased autoantibody level [MP:0003725]| decreased autoantibody level [MP:0003726]| abnormal retinal inner nuclear layer morphology [MP:0003733]| abnormal bone structure [MP:0003795]| impaired macrophage chemotaxis [MP:0003799]| vascular smooth muscle hypoplasia [MP:0003814]| enhanced coordination [MP:0003858]| abnormal myelin sheath morphology [MP:0003871]| decreased macrophage cell number [MP:0003884]| abnormal ST segment [MP:0003897]| decreased kidney weight [MP:0003918]| abnormal lymphocyte physiology [MP:0003945]| abnormal cholesterol level [MP:0003947]| abnormal circulating lipid level [MP:0003949]| increased circulating VLDL triglyceride level [MP:0003975]| increased circulating phospholipid level [MP:0003980]| increased cholesterol level [MP:0003982]| decreased cholesterol level [MP:0003983]| arteriosclerosis [MP:0003991]| aortic dissection [MP:0004044]| abnormal coronary artery morphology [MP:0004111]| abnormal aortic arch morphology [MP:0004113]| increased compact bone thickness [MP:0004148]| increased renal tubule apoptosis [MP:0004153]| abnormal basilar membrane morphology [MP:0004308]| cochlear inner hair cell degeneration [MP:0004398]| cochlear outer hair cell degeneration [MP:0004404]| abnormal spiral modiolar artery morphology [MP:0004629]| spiral modiolar artery stenosis [MP:0004630]| increased anti-double stranded DNA antibody level [MP:0004762]| abnormal synaptic vesicle morphology [MP:0004769]| increased macrophage derived foam cell number [MP:0004778]| increased anti-nuclear antigen antibody level [MP:0004794]| increased susceptibility to systemic lupus erythematosus [MP:0004801]| increased mean systemic arterial blood pressure [MP:0004875]| decreased systemic vascular resistance [MP:0004879]| abnormal vascular wound healing [MP:0004883]| decreased adiponectin level [MP:0004893]| increased uterus weight [MP:0004904]| skin inflammation [MP:0004947]| increased spleen weight [MP:0004952]| abnormal osteoblast physiology [MP:0005006]| increased B cell number [MP:0005014]| increased T cell number [MP:0005015]| decreased T cell number [MP:0005018]| increased susceptibility to parasitic infection [MP:0005027]| abnormal thrombosis [MP:0005048]| decreased acute inflammation [MP:0005087]| decreased cardiac muscle contractility [MP:0005140]| increased circulating VLDL cholesterol level [MP:0005145]| decreased circulating VLDL cholesterol level [MP:0005146]| abnormal blood-brain barrier function [MP:0005167]| increased circulating cholesterol level [MP:0005178]| decreased circulating cholesterol level [MP:0005179]| glomerulosclerosis [MP:0005264]| abnormal cholesterol homeostasis [MP:0005278]| improved glucose tolerance [MP:0005292]| impaired glucose tolerance [MP:0005293]| abnormal circulating amino acid level [MP:0005311]| increased triglyceride level [MP:0005317]| abnormal enzyme/coenzyme level [MP:0005319]| abnormal renal glomerulus morphology [MP:0005325]| insulin resistance [MP:0005331]| abnormal gonadal fat pad morphology [MP:0005335]| atherosclerotic lesions [MP:0005338]| increased susceptibility to atherosclerosis [MP:0005339]| altered susceptibility to atherosclerosis [MP:0005340]| decreased susceptibility to atherosclerosis [MP:0005341]| abnormal bile salt homeostasis [MP:0005365]| vascular stenosis [MP:0005412]| abnormal circulating protein level [MP:0005416]| increased macrophage cell number [MP:0005425]| increased susceptibility to weight gain [MP:0005455]| vascular smooth muscle hyperplasia [MP:0005489]| abnormal eye electrophysiology [MP:0005551]| increased circulating creatinine level [MP:0005553]| increased circulating glucose level [MP:0005559]| decreased circulating glucose level [MP:0005560]| abnormal enzyme/coenzyme activity [MP:0005584]| increased vasodilation [MP:0005590]| decreased vasodilation [MP:0005591]| abnormal vascular smooth muscle morphology [MP:0005592]| abnormal vascular smooth muscle physiology [MP:0005595]| decreased susceptibility to type IV hypersensitivity reaction [MP:0005616]| decreased susceptibility to diet-induced obesity [MP:0005659]| decreased circulating leptin level [MP:0005668]| increased circulating leptin level [MP:0005669]| increased apoptosis [MP:0006042]| abnormal vascular endothelial cell morphology [MP:0006055]| decreased cerebral infarction size [MP:0006058]| increased cerebral infarction size [MP:0006060]| abnormal circulating homocysteine level [MP:0006076]| increased fat cell size [MP:0006094]| calcified artery [MP:0006133]| artery occlusion [MP:0006134]| increased systemic arterial systolic blood pressure [MP:0006144]| decreased systemic arterial systolic blood pressure [MP:0006264]| aortic aneurysm [MP:0006278]| abnormal T cell number [MP:0006387]| delayed cellular replicative senescence [MP:0008009]| impaired lipolysis [MP:0008033]| abnormal CD4-positive [MP:0008073]| alpha beta T cell number [MP:0008074]| increased CD4-positive [MP:0008075]| alpha beta T cell number [MP:0008079]| decreased CD4-positive [MP:0008090]| alpha beta T cell number [MP:0008143]| decreased CD8-positive [MP:0008174]| alpha-beta T cell number [MP:0008181]| increased T-helper 2 cell number [MP:0008182]| abnormal dendrite morphology [MP:0008217]| decreased follicular B cell number [MP:0008243]| increased marginal zone B cell number [MP:0008248]| decreased marginal zone B cell number [MP:0008288]| abnormal B cell activation [MP:0008289]| abnormal macrophage derived foam cell morphology [MP:0008389]| abnormal mononuclear phagocyte morphology [MP:0008406]| abnormal adrenal cortex morphology [MP:0008428]| abnormal adrenal medulla morphology [MP:0008511]| hypochromic macrocytic anemia [MP:0008515]| increased cellular sensitivity to hydrogen peroxide [MP:0008544]| abnormal spatial working memory [MP:0008553]| thin retinal inner nuclear layer [MP:0008561]| thin retinal outer nuclear layer [MP:0008566]| impaired olfaction [MP:0008567]| increased circulating tumor necrosis factor level [MP:0008577]| decreased tumor necrosis factor secretion [MP:0008596]| increased interferon-gamma secretion [MP:0008597]| decreased interferon-gamma secretion [MP:0008617]| increased circulating interferon-gamma level [MP:0008660]| increased circulating interleukin-6 level [MP:0008817]| decreased circulating interleukin-6 level [MP:0008916]| increased circulating interleukin-12 level [MP:0009278]| increased interleukin-10 secretion [MP:0009289]| hematoma [MP:0009346]| abnormal astrocyte physiology [MP:0009538]| abnormal bone marrow cell physiology [MP:0009763]| decreased epididymal fat pad weight [MP:0009764]| decreased trabecular bone thickness [MP:0009814]| abnormal synapse morphology [MP:0009862]| increased sensitivity to induced morbidity/mortality [MP:0009864]| decreased sensitivity to induced morbidity/mortality [MP:0009866]| increased prostaglandin level [MP:0009868]| abnormal aorta elastic tissue morphology [MP:0009873]| abnormal aorta endothelium morphology [MP:0009932]| abnormal aorta wall morphology [MP:0010210]| abnormal descending thoracic aorta morphology [MP:0010451]| abnormal aorta tunica media morphology [MP:0010483]| skin fibrosis [MP:0010574]| abnormal circulating cytokine level [MP:0010658]| kidney microaneurysm [MP:0010659]| aortic sinus aneurysm [MP:0010663]| aorta dilation [MP:0010724]| thoracic aorta aneurysm [MP:0010760]| abdominal aorta aneurysm [MP:0010868]| abnormal brachiocephalic trunk morphology [MP:0010869]| thick interventricular septum [MP:0010879]| abnormal macrophage chemotaxis [MP:0010895]| increased bone trabecula number [MP:0010922]| decreased bone trabecula number [MP:0010933]| decreased trabecular bone volume [MP:0010935]| increased lung compliance [MP:0010950]| alveolitis [MP:0011086]| decreased trabecular bone connectivity density [MP:0011231]| increased airway resistance [MP:0011294]| abnormal lung hysteresivity [MP:0011309]| postnatal lethality [MP:0011339]| incomplete penetrance [MP:0011353]| abnormal vitamin E level [MP:0011368]| renal glomerulus hypertrophy [MP:0011430]| abnormal kidney arterial blood vessel morphology [MP:0011477]| abnormal glomerular mesangium morphology [MP:0011508]| expanded mesangial matrix [MP:0011509]| increased kidney apoptosis [MP:0011561]| mesangiolysis [MP:0011567]| abnormal urine nucleoside level [MP:0011572]| glomerular capillary thrombosis [MP:0011578]| dilated glomerular capillary [MP:0011581]| renal glomerulus lipidosis [MP:0011599]| increased renal glomerulus lobularity [MP:0011939]| abnormal aorta bulb morphology [MP:0011941]| increased lipoprotein lipase activity [MP:0011951]| increased triglyceride lipase activity [MP:0011967]| increased phosphatidylcholine-sterol O-acyltransferase activity [MP:0012307]| increased food intake [MP:0012335]| increased fluid intake [MP:0013022]| increased cardiac stroke volume [MP:0014169]| increased or absent threshold for auditory brainstem response [MP:0020253]| impaired spatial learning [MP:0020408]| increased circulating homocysteine level [MP:0020519] | Plau||MSR1||Apoe | 067987-MU | Transgenic | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | PMID:15096455 PMID:15297377 PMID:16554301 PMID:27262672 PMID:23536772 PMID:20380835 |
MMRRC_67987-MU, MMRRC_067987, MMRRC_67987 | 2026-07-25 09:48:22 | 0 | |||
|
STOCK Gpd2tm1Tka Slc25a13tm1Lct/Mmjax Resource Report Resource Website Issue |
RRID:MMRRC_069611-JAX | Mus musculus | Research areas: Metabolism, Models for Human Disease, Research Tools; Mutation Type: Targeted Mutation ; Collection: | hypoglycemia [MP:0000189]| decreased body weight [MP:0001262]| increased circulating free fatty acid level [MP:0001554]| postnatal growth retardation [MP:0001732]| premature death [MP:0002083]| hepatic steatosis [MP:0002628]| decreased circulating insulin level [MP:0002727]| increased circulating alkaline phosphatase level [MP:0002968]| abnormal gluconeogenesis [MP:0003383]| increased circulating glycerol level [MP:0003443]| increased circulating ammonia level [MP:0005309]| abnormal circulating amino acid level [MP:0005311]| abnormal amino acid level [MP:0005332]| increased liver triglyceride level [MP:0009355]| abnormal blood homeostasis [MP:0009642]| abnormal urine homeostasis [MP:0009643]| hypoglycemia [MP:0000189]| decreased body weight [MP:0001262]| decreased body size [MP:0001265]| abnormal eating behavior [MP:0001431]| increased circulating free fatty acid level [MP:0001554]| postnatal growth retardation [MP:0001732]| premature death [MP:0002083]| hepatic steatosis [MP:0002628]| decreased circulating insulin level [MP:0002727]| increased circulating alkaline phosphatase level [MP:0002968]| decreased insulin secretion [MP:0003059]| increased circulating glycerol level [MP:0003443]| increased circulating cholesterol level [MP:0005178]| decreased oxygen consumption [MP:0005290]| increased circulating ammonia level [MP:0005309]| abnormal circulating amino acid level [MP:0005311]| abnormal amino acid level [MP:0005332]| abnormal triiodothyronine level [MP:0005472]| increased circulating thyroxine level [MP:0005477]| increased circulating triiodothyronine level [MP:0005480]| increased body temperature [MP:0005533]| decreased brown fat cell lipid droplet size [MP:0009125]| increased liver triglyceride level [MP:0009355]| abnormal blood homeostasis [MP:0009642]| impaired adaptive thermogenesis [MP:0011049]| decreased brown adipose tissue mass [MP:0014169] | |Gpd2||Slc25a13 | 069611-JAX | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | PMID:17591776 PMID:14701727 |
MMRRC_69611-JAX, MMRRC_069611, MMRRC_69611 | 2026-07-25 09:48:29 | 0 | |||
|
C.129-Slc25a13tm1Lct/SinaMmjax Resource Report Resource Website Issue |
RRID:MMRRC_069594-JAX | Mus musculus | Research areas: Metabolism; Mutation Type: Targeted Mutation ; Collection: | hypoglycemia [MP:0000189]| decreased body weight [MP:0001262]| increased circulating free fatty acid level [MP:0001554]| postnatal growth retardation [MP:0001732]| premature death [MP:0002083]| hepatic steatosis [MP:0002628]| decreased circulating insulin level [MP:0002727]| increased circulating alkaline phosphatase level [MP:0002968]| abnormal gluconeogenesis [MP:0003383]| increased circulating glycerol level [MP:0003443]| increased circulating ammonia level [MP:0005309]| abnormal circulating amino acid level [MP:0005311]| abnormal amino acid level [MP:0005332]| increased liver triglyceride level [MP:0009355]| abnormal blood homeostasis [MP:0009642]| abnormal urine homeostasis [MP:0009643] | Slc25a13 | 069594-JAX | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | PMID:14701727 | MMRRC_69594-JAX, MMRRC_069594, MMRRC_69594 | 2026-07-25 09:48:29 | 0 | |||
|
C.129S7(B6)-Itgb2tm2Bay/AbhmJ Resource Report Resource Website 1+ mentions Issue |
RRID:IMSR_JAX:027003 | Mus musculus | gene symbol note: integrin beta 2; mutant strain|congenic strain: Itgb2 | integrin beta 2 | targeted mutation 2; Baylor College of Medicine | JAX:027003 | JAX Mice and Services | JAX | sperm | 2026-07-24 09:45:05 | 1 | |||||
|
NOD.Cg-B2mtm1Unc Tg(B2M)55Hpl Tg(HLA-A*1101/H2-K Resource Report Resource Website 1+ mentions Issue |
RRID:IMSR_JAX:027849 | Mus musculus |
NOD.mbeta2m |
gene symbol note: transgene insertion 55; Hidde Ploegh|major histocompatibility complex; class I; A; human and histocompatibility 2; K region fusion gene|beta-2 microglobulin|transgene insertion; Alessandro Sette|beta-2-microglobulin; mutant strain|congenic strain: Tg(B2M)55Hpl|HLA-A/H2-K|B2m|Tg(HLA-A*1101/H2-K)#Sette|B2M | transgene insertion 55; Hidde Ploegh|major histocompatibility complex; class I; A; human and histocompatibility 2; K region fusion gene|beta-2 microglobulin|transgene insertion; Alessandro Sette|beta-2-microglobulin | transgene insertion 55; Hidde Ploegh|transgene insertion; Alessandro Sette|targeted mutation 1; University of North Carolina | JAX:027849 | JAX Mice and Services | JAX | embryo | 2026-07-24 09:45:08 | 2 | ||||
|
NOD.129S2(B6)-Il6tm1Kopf/YgchJ Resource Report Resource Website 1+ mentions Issue Issue |
RRID:IMSR_JAX:029264 | Mus musculus | gene symbol note: interleukin 6; mutant strain|congenic strain: Il6 | interleukin 6 | targeted mutation 1; Manfred Kopf | JAX:029264 | JAX Mice and Services | JAX | sperm | 2026-07-24 09:45:13 | 1 |
Can't find your Organism?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific organism, it's easier to enter an RRID or a Catalog Number to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your organism in the search results, please help us by registering it into the system — it's easy. Organisms identifiers are registered through multiple sources depending on the species:
Welcome to the nidm-terms Resources search. From here you can search through a compilation of resources used by nidm-terms and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that nidm-terms has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on nidm-terms then you can log in from here to get additional features in nidm-terms such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into nidm-terms you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
